NewAmsterdam Pharma Announces Closing of Upsized $479.0 …

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares ... for whom existing therapies are not sufficiently effective or well-tolerated, …

newamsterdampharma.com

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024  · NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the …

yahoo.com

NAMS Press Release: NewAmsterdam Pharma Announces Closing …

3 weeks from now

Read Press Release for Newamsterdam Pharma Company N.V. - (NAMS) published on Dec. 13, 2024 - NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering …

marketchameleon.com

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024  · NewAmsterdam Pharma (NAMS) has successfully closed its upsized public offering, raising $479.0 million through the sale of securities. The offering included 14,667,347 …

stocktitan.net

NewAmsterdam Pharma Announces Closing Of Upsized ... - The …

3 weeks from now

Dec 14, 2024  · NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the …

manilatimes.net

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 12, 2024  · NewAmsterdam Pharma Announces Closing of $479.0 Million Upsized Public Offering, Expanding Resources for Cardiovascular Disease InnovationsIn a significant stride …

csimarket.com

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024  · NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin

einpresswire.com

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, …

ceo.ca

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024  · Comprehensive suite of tools for trading and investing in biotech stocks. FDA Calendar, PDUFA Date Calendar, Biotech Company Screener and Database and much more

biopharmcatalyst.com

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024  · NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the …

sherbrookerecord.com

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 14, 2024  · MORE. Politics. All Foreign Affairs Cross-strait

taiwannews.com.tw

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024  · NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the …

yahoo.com

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

Dec 13, 2024  · NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the …

financialcontent.com

NewAmsterdam Pharma Announces Closing Of Upsized $479.0

3 weeks from now

Dec 13, 2024  · NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the …

tradingview.com